Literature DB >> 23896546

Deep brain stimulation of the globus pallidus suppresses post-traumatic dystonic tremor.

Karen S Carvalho1, Vishad V Sukul2, Markus J Bookland2, Steven A Koch3, Patrick J Connolly4.   

Abstract

Dystonic tremor is an unusual movement disorder that is highly disabling and difficult to treat medically. We describe an 18-year-old patient with dystonic tremor whose medical treatment failed, and was considered for surgery. The patient had a long-standing dystonic tremor and was recommended for globus pallidus (GP) deep brain stimulation. At 2 year follow-up, we observed substantial tremor suppression and best clinical effect with contact three, which, radiographically, is located in the internal globus pallidus/external globus pallidus transition area. The stimulation was more rostral than expected. We conclude that the GP is a potentially useful therapeutic target for dystonic tremor.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain trauma; Dystonia; Dystonic tremor; Stimulation; Surgery

Mesh:

Year:  2013        PMID: 23896546     DOI: 10.1016/j.jocn.2013.02.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

Review 1.  Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence.

Authors:  Shasha Li; Ana Luiza Zaninotto; Iuri Santana Neville; Wellingson Silva Paiva; Danuza Nunn; Felipe Fregni
Journal:  Neuropsychiatr Dis Treat       Date:  2015-06-30       Impact factor: 2.570

Review 2.  Hippocampal Neurophysiologic Changes after Mild Traumatic Brain Injury and Potential Neuromodulation Treatment Approaches.

Authors:  Fady Girgis; Jonathan Pace; Jennifer Sweet; Jonathan P Miller
Journal:  Front Syst Neurosci       Date:  2016-02-09

3.  Deep brain stimulation in post-traumatic dystonia: A case series study.

Authors:  Hong-Xia Li; Lu He; Chen-Cheng Zhang; Robert Eisinger; Yi-Xin Pan; Tao Wang; Bo-Min Sun; Yi-Wen Wu; Dian-You Li
Journal:  CNS Neurosci Ther       Date:  2019-04-29       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.